AI assistant
Sending…
Cytosorbents Corp — Director's Dealing 2021
Dec 14, 2021
34501_dirs_2021-12-13_b625969e-fe6f-426d-b0fc-03bc7da83a1e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2021-12-09
Reporting Person: Jones Edward Raymond (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-09 | Common Stock | M | 4000 | $4.125 | Acquired | 82800 | Direct |
| 2021-12-09 | Common Stock | F | 3161 | $5.22 | Disposed | 79639 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-09 | Stock Option (right to buy) | $4.125 | M | 4000 | Disposed | 2022-01-18 | Common Stock (4000) | Direct |
More from Cytosorbents Corp
Annual Report
2026
Apr 15
Delisting Announcement
2026
Apr 2
Annual Report
2026
Mar 30
Earnings Release
2026
Mar 25
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2025
Nov 21
Earnings Release
2025
Nov 13
Interim / Quarterly Report
2025
Nov 13
Delisting Announcement
2025
Oct 3
Regulatory Filings
2025
Sep 16